Harvesting Human Prostate Tissue Material and Culturing Primary Prostate Epithelial Cells

  • Fiona M. FrameEmail author
  • Davide Pellacani
  • Anne T. Collins
  • Norman J. MaitlandEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1443)


In order to fully explore the biology of a complex solid tumor such as prostate cancer, it is desirable to work with patient tissue. Only by working with cells from a tissue can we take into account patient variability and tumor heterogeneity. Cell lines have long been regarded as the workhorse of cancer research and it could be argued that they are of most use when considered within a panel of cell lines, thus taking into account specified mutations and variations in phenotype between different cell lines. However, often very different results are obtained when comparing cell lines to primary cells cultured from tissue. It stands to reason that cells cultured from patient tissue represents a close-to-patient model that should and does produce clinically relevant data. This chapter aims to illustrate the methods of processing, storing and culturing cells from prostate tissue, with a description of potential uses.

Key words

Prostate Tissue Primary epithelial cells Cancer Benign prostatic hyperplasia 



This work was supported by a Yorkshire Cancer Research Core Grant (Y257PA). Photo credits to: Paula Kroon, Rachel Adamson, Shona Lang, Paul Berry, Stephanie Swift.


  1. 1.
    Chaproniere DM, McKeehan WL (1986) Serial culture of single adult human prostatic epithelial cells in serum-free medium containing low calcium and a new growth factor from bovine brain. Cancer Res 46(2):819–824PubMedGoogle Scholar
  2. 2.
    McKeehan WL, Adams PS, Rosser MP (1984) Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture. Cancer Res 44(5):1998–2010PubMedGoogle Scholar
  3. 3.
    Frame FM et al (2010) Development and limitations of lentivirus vectors as tools for tracking differentiation in prostate epithelial cells. Exp Cell Res 316(19):3161–3171CrossRefPubMedGoogle Scholar
  4. 4.
    Hager S et al (2008) An internal polyadenylation signal substantially increases expression levels of lentivirus-delivered transgenes but has the potential to reduce viral titer in a promoter-dependent manner. Hum Gene Ther 19(8):840–850CrossRefPubMedGoogle Scholar
  5. 5.
    Polson ES et al (2013) Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cells. Nat Commun 4:1623CrossRefPubMedGoogle Scholar
  6. 6.
    Kroon P et al (2013) JAK-STAT blockade inhibits tumor initiation and clonogenic recovery of prostate cancer stem-like cells. Cancer Res 73(16):5288–5298CrossRefPubMedGoogle Scholar
  7. 7.
    Oldridge EE et al (2013) Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXN. Oncogenesis 2:e45CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Pellacani D et al (2014) DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation. Cell Death Differ 21(5):761–773CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Pellacani D et al (2011) Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer. Mol Cancer 10:94CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Swift SL, Burns JE, Maitland NJ (2010) Altered expression of neurotensin receptors is associated with the differentiation state of prostate cancer. Cancer Res 70(1):347–356CrossRefPubMedGoogle Scholar
  11. 11.
    Collins AT et al (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65(23):10946–10951CrossRefPubMedGoogle Scholar
  12. 12.
    Adamson RE et al (2012) In vitro primary cell culture as a physiologically relevant method for preclinical testing of human oncolytic adenovirus. Hum Gene Ther 23(2):218–230CrossRefPubMedGoogle Scholar
  13. 13.
    Birnie R et al (2008) Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biol 9(5):R83CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Frame FM et al (2013) HDAC inhibitor confers radiosensitivity to prostate stem-like cells. Br J Cancer 109(12):3023–3033CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Rane JK et al (2014) Conserved two-step regulatory mechanism of human epithelial differentiation. Stem Cell Rep 2(2):180–188CrossRefGoogle Scholar
  16. 16.
    Guo C et al (2012) Epcam, CD44, and CD49f distinguish sphere-forming human prostate basal cells from a subpopulation with predominant tubule initiation capability. PLoS One 7(4):e34219CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Williamson SC et al (2012) Human alpha(2)beta(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor. PLoS One 7(11):e48944CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Jeter CR et al (2011) NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 30(36):3833–3845CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    van den Hoogen C et al (2010) High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res 70(12):5163–5173CrossRefPubMedGoogle Scholar
  20. 20.
    Garraway IP et al (2010) Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate 70(5):491–501PubMedPubMedCentralGoogle Scholar
  21. 21.
    Buhler P et al (2010) Primary prostate cancer cultures are models for androgen-independent transit amplifying cells. Oncol Rep 23(2):465–470PubMedGoogle Scholar
  22. 22.
    Jiang M et al (2010) Functional remodeling of benign human prostatic tissues in vivo by spontaneously immortalized progenitor and intermediate cells. Stem Cells 28(2):344–356PubMedPubMedCentralGoogle Scholar
  23. 23.
    Guzman-Ramirez N et al (2009) In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue. Prostate 69(15):1683–1693CrossRefPubMedGoogle Scholar
  24. 24.
    Attard G et al (2009) A novel, spontaneously immortalized, human prostate cancer cell line, Bob, offers a unique model for pre-clinical prostate cancer studies. Prostate 69(14):1507–1520CrossRefPubMedGoogle Scholar
  25. 25.
    Goldstein AS et al (2008) Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci U S A 105(52):20882–20887CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Brown MD et al (2007) Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations. Prostate 67(13):1384–1396CrossRefPubMedGoogle Scholar
  27. 27.
    Heer R et al (2006) KGF suppresses alpha2beta1 integrin function and promotes differentiation of the transient amplifying population in human prostatic epithelium. J Cell Sci 119(Pt 7):1416–1424CrossRefPubMedGoogle Scholar
  28. 28.
    Shepherd CJ et al (2008) Expression profiling of CD133+ and CD133- epithelial cells from human prostate. Prostate 68(9):1007–1024CrossRefPubMedGoogle Scholar
  29. 29.
    Niranjan B et al (2013) Primary culture and propagation of human prostate epithelial cells. Methods Mol Biol 945:365–382CrossRefPubMedGoogle Scholar
  30. 30.
    Blow NS (2011) Right cell, wrong cell. BioTechniques 51(2):75PubMedGoogle Scholar
  31. 31.
    Nardone RM (2008) Curbing rampant cross-contamination and misidentification of cell lines. BioTechniques 45(3):221–227CrossRefPubMedGoogle Scholar
  32. 32.
    Phuchareon J et al (2009) Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2. PLoS One 4(6):e6040CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Barallon R et al (2010) Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues. In vitro cellular & developmental biology. Animal 46(9):727–732Google Scholar
  34. 34.
    Schenk E et al (2014) Preclinical safety assessment of Ad[I/PPT-E1A], a novel oncolytic adenovirus for prostate cancer. Human gene therapy. Clin Dev 25(1):7–15Google Scholar
  35. 35.
    Ulukaya E et al (2013) Differential cytotoxic activity of a novel palladium-based compound on prostate cell lines, primary prostate epithelial cells and prostate stem cells. PLoS One 8(5):e64278CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Niu J, Zhang B, Chen H (2014) Applications of TALENs and CRISPR/Cas9 in human cells and their potentials for gene therapy. Mol Biotechnol 56(8):681–688CrossRefPubMedGoogle Scholar
  37. 37.
    Maitland NJ et al (2010) Prostate cancer stem cells: do they have a basal or luminal phenotype? Horm Cancer 2(1):47–61CrossRefGoogle Scholar
  38. 38.
    Hudson DL et al (2001) Epithelial cell differentiation pathways in the human prostate: identification of intermediate phenotypes by keratin expression. J Histochem Cytochem 49(2):271–278CrossRefPubMedGoogle Scholar
  39. 39.
    Hudson DL et al (2000) Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells. Lab Investig 80(8):1243–1250CrossRefPubMedGoogle Scholar
  40. 40.
    Collins AT et al (2001) Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J Cell Sci 114(Pt 21):3865–3872PubMedGoogle Scholar
  41. 41.
    Richardson GD et al (2004) CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117(Pt 16):3539–3545CrossRefPubMedGoogle Scholar
  42. 42.
    Robinson EJ, Neal DE, Collins AT (1998) Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate 37(3):149–160CrossRefPubMedGoogle Scholar
  43. 43.
    Rane JK, Pellacani D, Maitland NJ (2012) Advanced prostate cancer--a case for adjuvant differentiation therapy. Nat Rev Urol 9(10):595–602CrossRefPubMedGoogle Scholar
  44. 44.
    Nagle RB et al (1987) Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. Cancer Res 47(1):281–286PubMedGoogle Scholar
  45. 45.
    Humphrey PA (2007) Diagnosis of adenocarcinoma in prostate needle biopsy tissue. J Clin Pathol 60(1):35–42CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    El-Alfy M et al (2000) Unique features of the basal cells of human prostate epithelium. Microsc Res Tech 51(5):436–446CrossRefPubMedGoogle Scholar
  47. 47.
    Chambers KF et al (2011) Stroma regulates increased epithelial lateral cell adhesion in 3D culture: a role for actin/cadherin dynamics. PLoS One 6(4):e18796CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Lang SH et al (2010) Modeling the prostate stem cell niche: an evaluation of stem cell survival and expansion in vitro. Stem Cells Dev 19(4):537–546CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Lang SH et al (2001) Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures. Br J Cancer 85(4):590–599CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Lang SH et al (2006) Differentiation of prostate epithelial cell cultures by Matrigel/stromal cell glandular reconstruction. In vitro cellular & developmental biology. Animal 42(8–9):273–280Google Scholar
  51. 51.
    Lang SH et al (2001) Experimental prostate epithelial morphogenesis in response to stroma and three-dimensional Matrigel culture. Cell Growth Differ 12(12):631–640PubMedGoogle Scholar
  52. 52.
    Pearson JF et al (2009) Polarized fluid movement and not cell death, creates luminal spaces in adult prostate epithelium. Cell Death Differ 16(3):475–482CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.YCR Cancer Research Unit, Department of BiologyUniversity of YorkHeslington, North YorkshireUK

Personalised recommendations